Rapid7 Nexpose Update Validation Issue
CVE-2022-4261
4.4MEDIUM
What is CVE-2022-4261?
Rapid7 Nexpose and InsightVM versions prior to 6.6.172 failed to reliably validate the authenticity of update contents. This failure could allow an attacker to provide a malicious update and alter the functionality of Rapid7 Nexpose. The attacker would need some pre-existing mechanism to provide a malicious update, either through a social engineering effort, privileged access to replace downloaded updates in transit, or by performing an Attacker-in-the-Middle attack on the update service itself.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.
Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.
Affected Version(s)
InsightVM 0 <= 6.6.171
Nexpose 0 <= 6.6.171
References
CVSS V3.1
Score:
4.4
Severity:
MEDIUM
Confidentiality:
None
Integrity:
High
Availability:
None
Attack Vector:
Local
Attack Complexity:
High
Privileges Required:
Low
User Interaction:
Required
Scope:
Unchanged
Timeline
Vulnerability published
Credit
Emmett Kelly, Rapid7 Principal Software Engineer
